BioNTech SE - American Depositary Shares (NQ:BNTX)

97.32 +0.42 (+0.43%)

Delayed Quote Updated: 2:11 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioNTech SE - American Depositary Shares

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

73 74 Next >

Landmark Drug Pricing Reform Bill Passes Congress House ↗

August 15, 2022

The U.S. House of Representatives voted 220-207 to pass new, wide-ranging legislation allowing Medicare drug price negotiations for the first time and capping seniors’ drug expenses to $2,000 per year...

Via Benzinga

Stock Market Rally Rises On Inflation Data; Nvidia, Micron, Tesla, Disney In Focus: Weekly Review ↗

August 12, 2022

The major indexes continued to advance, despite some key warnings.

Via Investor's Business Daily

Pharmaceutical Companies Report Gearing Up To Combat COVID Variants This Fall ↗

August 11, 2022

The more contagious omicron BA.4 and BA.5 COVID-19 variants are dominant in all parts of the United States, making up more than 70% of infections.

Via Benzinga

BioNTech Whale Trades For August 09 ↗

August 09, 2022

A whale with a lot of money to spend has taken a noticeably bullish stance on BioNTech. Looking at options history for BioNTech (NASDAQ:BNTX) we detected 10 strange trades.

Via Benzinga

Why Is BioNTech (BNTX) Stock Down 7% Today? ↗

August 08, 2022

BioNTech (BNTX) stock is on falling on Monday after the company released poor earnings results for its second quarter of 2022.

Via InvestorPlace

BioNTech Dives As Second-Quarter Sales, Profit Broadly Miss Forecasts ↗

August 08, 2022

The company's retained guidance was also weak at the midpoint.

Via Investor's Business Daily

Global Multiple Sclerosis Drugs Market Size Projected To Reach $33 Billion By 2029

August 11, 2022

Palm Beach, FL –– August 11, 2022 – FinancialNewsMedia.com News Commentary – Multiple Sclerosis (MS) is an immune-mediated disease affecting the central nervous system. It is characterized by...

Via FinancialNewsMedia

Twitter To $50? Here Are 5 Other Price Target Changes For Wednesday ↗

August 10, 2022

Wedbush boosted the price target on Twitter, Inc. (NYSE: TWTR) from $30 to $50. Wedbush analyst Daniel Ives maintained the stock with a Neutral rating. Twitter shares rose 3.4% to $44.29 in pre-market...

Via Benzinga

7 Blue-Chip Stocks That Will Survive 2022 ↗

August 09, 2022

These are among the best blue-chip stocks to buy now. Here's why ABBV, BDX, CI, DD, MMM, JPM, and PFE can make great investments.

Via InvestorPlace

Recap: BioNTech Q2 Earnings ↗

August 08, 2022

BioNTech (NASDAQ:BNTX) reported its Q2 earnings results on Monday, August 8, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Genmab, BioNTech Join Forces For Cancer Immunotherapy Candidates ↗

August 05, 2022

Via Benzinga

Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday ↗

August 09, 2022

Gainers Helbiz, Inc. (NASDAQ: HLBZ) jumped 114.6% to close at $1.61 on Monday after climbing over 27% on Friday.

Via Benzinga

Fear & Greed Index Remains In 'Neutral' Zone As Investors Await Wednesday's Inflation Report ↗

August 09, 2022

The U.S. stock markets remained in the "neutral" zone on Tuesday, according to the CNN Money Fear and Greed index. Wall Street closed mixed on Friday after a New York Federal Reserve survey showed U.S....

Via Benzinga

Here's What's Going On With Novavax Shares ↗

August 08, 2022

Novavax, Inc. (NASDAQ: NVAX) shares are trading lower by 3.05% to $58.43 Monday afternoon in sympathy with BioNTech SE - ADR (NASDAQ: BNTX), which reported worse-than-expected second-quarter results.

Via Benzinga

Why Moderna Shares Are Falling Following BioNTech's Earnings Results ↗

August 08, 2022

Moderna Inc (NASDAQ: MRNA) shares are trading lower by 2.32% to $182.50 Monday afternoon in sympathy with BioNTech SE - ADR (NASDAQ: BNTX), which reported worse-than-expected second-quarter results.

Via Benzinga

Why These Pfizer Analysts Like The Global Blood Therapeutics Deal ↗

August 08, 2022

Pfizer Inc. (NYSE: PFE) shares were trading lower Monday after the drugmaker announced a $5.4-billion bid to acquire blood disorder drugmaker Global Blood Therapeutics Inc (NASDAQ: GBT).

Via Benzinga

Equity Index Futures Slightly Higher As U.S. Dollar Retreats ↗

August 08, 2022

(Monday Market Open) Equity index futures pointed to a higher open as the U.S. dollar retreated from Friday’s rally.

Via Benzinga

Why CinCor Pharma Is Trading Higher By 63%, Here Are 79 Stocks Moving In Monday's Mid-Day Session ↗

August 08, 2022

Gainers Bonso Electronics International Inc. (NASDAQ: BNSO) shares jumped 132% to $11.12 after jumping around 46% on Friday. The company recently said it expects unaudited comprehensive loss of $1.6...

Via Benzinga

NVIDIA, Tyson Foods, BioNTech And Some Other Big Stocks Moving Lower On Monday ↗

August 08, 2022

AMTD Digital Inc. (NYSE: HKD) dipped 21.8% to $563.71 on possible profit taking after the stock surged over the last few trading days.

Via Benzinga

Karuna Therapeutics (KRTX) Stock Soars 64% on Positive Clinical Data ↗

August 08, 2022

Karuna Therapeutics (KRTX) stock is rocketing higher on Monday thanks to results from a Phase 3 EMERGENT-2 trial to treat schizophrenia.

Via InvestorPlace

Benzinga Before The Bell: Elon Musk Confirms Tesla AI Day Part 2, Dogecoin Scam, BioNTech Q2 Earnings Shocker And Other Top Financial Stories Monday, August 8 ↗

August 08, 2022

CNBC Celsius Withdraws Motion To Rehire CFO

Via Benzinga

Tesla, Signify Health And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

August 08, 2022

Via Benzinga

BioNTech Earnings Shocker: Posts Lower Than Expected Q2 Profits, Revenues Fall ↗

August 08, 2022

Via Benzinga

Why Is NuZee Down By Over 21%: Here Are 38 Stocks Moving Premarket ↗

August 08, 2022

Gainers Bonso Electronics International Inc. (NASDAQ: BNSO) shares rose 46% to $6.98 in pre-market trading after jumping around 46% on Friday. The company recently said it expects unaudited...

Via Benzinga

U.S. Stock Futures Higher After Friday's Jobs Report ↗

August 08, 2022

Pre-open movers

Via Benzinga

Tyson Foods, Take-Two Interactive And 3 Stocks To Watch Heading Into Monday ↗

August 08, 2022

With US stock futures trading slightly higher this morning on Monday following the release of upbeat of jobs report on Friday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Disney Leads Media Earnings This Week As Reporting Season Moves Past The Peak ↗

August 07, 2022

We are past the peak of earnings season, and about 87% of the S&P 500 companies have already released their quarterly numbers, FactSet reports.

Via Benzinga

Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases ↗

August 05, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

A Flurry Of Employment News Drops Ahead Of Friday's Jobs Report ↗

August 04, 2022

(Thursday Market Open) The Bank of England (BoE) raised its key lending rate by 50 basis points, its biggest hike in 27 years.

Via Benzinga

Here's Why BioNTech Stock Is Moving ↗

August 03, 2022

BioNTech SE - ADR (NASDAQ: BNTX) shares are trading higher in sympathy with Moderna Inc (NASDAQ: MRNA), which reported better-than-expected second-quarter results.

Via Benzinga

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

73 74 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.